294 related articles for article (PubMed ID: 37100255)
1. Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies.
Yang Y; Jiang G; Huang R; Liu Y; Chang X; Fu S
Biochem Pharmacol; 2023 Jun; 212():115569. PubMed ID: 37100255
[TBL] [Abstract][Full Text] [Related]
2. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy.
Zheng X; Wan J; Tan G
Front Immunol; 2023; 14():1151185. PubMed ID: 37180116
[TBL] [Abstract][Full Text] [Related]
3. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
4. Targeted P2X7/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy.
Kong H; Zhao H; Chen T; Song Y; Cui Y
Cell Death Dis; 2022 Apr; 13(4):336. PubMed ID: 35410316
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy.
Lepre CC; Russo M; Trotta MC; Petrillo F; D'Agostino FA; Gaudino G; D'Amico G; Campitiello MR; Crisci E; Nicoletti M; Gesualdo C; Simonelli F; D'Amico M; Hermenean A; Rossi S
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298672
[TBL] [Abstract][Full Text] [Related]
6. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
Louie HH; Shome A; Kuo CY; Rupenthal ID; Green CR; Mugisho OO
Exp Eye Res; 2021 Jan; 202():108384. PubMed ID: 33285185
[TBL] [Abstract][Full Text] [Related]
7. Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy.
Kuo CY; Maran JJ; Jamieson EG; Rupenthal ID; Murphy R; Mugisho OO
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430950
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets.
Raman KS; Matsubara JA
Ocul Immunol Inflamm; 2022 Feb; 30(2):470-478. PubMed ID: 33026924
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasome in endothelial dysfunction.
Bai B; Yang Y; Wang Q; Li M; Tian C; Liu Y; Aung LHH; Li PF; Yu T; Chu XM
Cell Death Dis; 2020 Sep; 11(9):776. PubMed ID: 32948742
[TBL] [Abstract][Full Text] [Related]
11. Role of pyroptosis in diabetic retinopathy and its therapeutic implications.
Al Mamun A; Mimi AA; Zaeem M; Wu Y; Monalisa I; Akter A; Munir F; Xiao J
Eur J Pharmacol; 2021 Aug; 904():174166. PubMed ID: 33979651
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy.
Zhang L; Ai C; Bai M; Niu J; Zhang Z
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142531
[TBL] [Abstract][Full Text] [Related]
13. Proanthocyanidins attenuate the high glucose-induced damage of retinal pigment epithelial cells by attenuating oxidative stress and inhibiting activation of the NLRP3 inflammasome.
Li H; Li R; Wang L; Liao D; Zhang W; Wang J
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22845. PubMed ID: 34338401
[TBL] [Abstract][Full Text] [Related]
14. [Protective effect of ginsenoside Rg_1 aganist diabetic retinopathy by inhibiting NLRP3 inflammasome in type 2 diabetic mice].
Li B; Zhang DC; Li XW; Dong XN; Li WP; Li WZ
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):476-483. PubMed ID: 35178992
[TBL] [Abstract][Full Text] [Related]
15. lncRNA HOTAIR promotes ROS generation and NLRP3 inflammasome activation by inhibiting Nrf2 in diabetic retinopathy.
You H; Li H; Gou W
Medicine (Baltimore); 2023 Sep; 102(37):e35155. PubMed ID: 37713847
[TBL] [Abstract][Full Text] [Related]
16. Dysfunctional Nurr1 promotes high glucose-induced Müller cell activation by up-regulating the NF-κB/NLRP3 inflammasome axis.
Li W; Liu X; Tu Y; Ding D; Yi Q; Sun X; Wang Y; Wang K; Zhu M; Mao J
Neuropeptides; 2020 Aug; 82():102057. PubMed ID: 32461025
[TBL] [Abstract][Full Text] [Related]
17. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
[TBL] [Abstract][Full Text] [Related]
18. Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome: A Narrative Review.
Yuan JY; Fu Y; Feng ZH; Sang F; Shao MY; Li LL
Chin J Integr Med; 2022 Aug; 28(8):753-761. PubMed ID: 35507299
[TBL] [Abstract][Full Text] [Related]
19. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy.
Chen H; Zhang X; Liao N; Mi L; Peng Y; Liu B; Zhang S; Wen F
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):978-985. PubMed ID: 29450537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
